No published trials measuring effectiveness of tofacitinib in COVID-19 have been identified. Some professional associations recommend discontinuing tofacitinib if SARS-CoV-2 infections is detected. Taken into account possible complications of the use of tofacitinib (infections. lymphopenia. https://missouriquiltcoes.shop/product-category/fat-eighth-bundles/